Par Pacific Hldgs (NYSE:PARR) Azioni

Par Pacific Hldgs

Par Pacific Holdings Inc is an oil and gas company that manages and maintains interests in energy and infrastructure businesses. The company has three reportable segments namely Refining, Under its refining business, the company produces ultra-low-sulfur diesel, gasoline, jet fuel, marine fuel, LSFO, and other associated refined products. Its Retail includes operation licenses out brands to serve the retail consumer. Through the Logistics segment, crude shipments are delivered to the refineries, in addition to finished products that are exported. It generates maximum revenue from the Refining segment.

Par Pacific Holdings Inc

Parrot SA

Latham Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SWIM#NASDAQ">SWIM</a>) affirms FY2025 sales outlook from $535.00 million-$565.00 million to $535.00 million-$565.00 million vs $540.58 million estimate.

News

Guidance

SWIM

Latham Group Affirms FY2025 Sales Guidance of $535.00M-$565.00M vs $540.58M Est

Golden Heaven Group Holdings Ltd. ("Golden Heaven" or the "Company") (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GDHG#NASDAQ">GDHG</a>), an amusement park operator in&nbsp;China, today announced that the Company's board of directors approved on April 23, 2025 that the authorized, issued, and outstanding shares of the Company be consolidated on a 25 for 1 ratio with the marketplace effective date of May 9, 2025.
The objective of the share consolidation is to enable the Company to regain compliance with Nasdaq Marketplace Rule 5550(a)(2) and maintain its listing on Nasdaq.
Beginning with the opening of trading on May 9, 2025, the Company's Class A ordinary shares will trade on the Nasdaq Capital Market on a split-adjusted basis, under the same symbol "GDHG" but under a new CUSIP Number, G3959D208.
As a result of the share consolidation, each 25 ordinary shares outstanding will automatically combine and convert to one issued and outstanding ordinary share without any action on the part of the shareholders. No fractional shares will be issued to any shareholders in connection with the share consolidation, and each shareholder will be entitled to receive one share of the Company in lieu of the fractional share of that class that would have resulted from the share consolidation.
At the time the share consolidation is effective, the Company's authorized share capital will be changed from US$200,600,000 divided into: (i) 40,000,000,000 Class A ordinary shares of par value of US$0.005 each, and (ii) 120,000,000 Class B ordinary shares of par value of US$0.005 each, to US$200,600,000 divided into: (i) 1,600,000,000 Class A ordinary shares with a par value of US$0.125 each, and (ii) 4,800,000 Class B ordinary shares with a par value of US$0.125 each. The Company's total issued and outstanding Class A ordinary shares will be changed from 74,323,604 Class A ordinary shares with a par value of US$0.005 each to approximately 2,972,944 Class A ordinary shares with a par value of US$0.125 each. The Company's total issued and outstanding Class B ordinary shares will be changed from 1,840,000 Class B ordinary shares with a par value of US$0.005 each to approximately 73,600 Class B ordinary shares with a par value of US$0.125 each.

GDHG

Golden Heaven Board Approves 25-for-1 Stock Consolidation Effective May 9, 2025

Sandstorm Gold (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SAND#NYSE">SAND</a>) reported quarterly earnings of $0.04 per share which met the analyst consensus estimate. This is a 500 percent increase over losses of $(0.01) per share from the same period last year. The company reported quarterly sales of $50.06 million which beat the analyst consensus estimate of $49.03 million by 2.10 percent. This is a 16.94 percent increase over sales of $42.81 million the same period last year.

Earnings

Earnings Beats

SAND

Sandstorm Gold Q1 EPS $0.04, Inline, Sales $50.06M Beat $49.03M Estimate

Agilon Health (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AGL#NYSE">AGL</a>) raises FY2025 sales outlook from $5.83 billion-$6.03 billion to $5.85 billion-$6.03 billion vs $5.93 billion estimate.

Agilon Health Raises FY2025 Sales Guidance from $5.83B-$6.03B to $5.85B-$6.03B vs $5.93B Est

Agilon Health (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AGL#NYSE">AGL</a>) sees Q2 sales of $1.435 billion-$1.505 billion vs $1.48 billion analyst estimate.

Agilon Health Sees Q2 Sales $1.435B-$1.505B vs $1.48B Est

California Resources (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CRC#NYSE">CRC</a>) reported quarterly earnings of $1.07 per share which beat the analyst consensus estimate of $0.78 by 37.18 percent. This is a 42.67 percent increase over earnings of $0.75 per share from the same period last year. The company reported quarterly sales of $912.00 million which beat the analyst consensus estimate of $861.21 million by 5.90 percent. This is a 100.88 percent increase over sales of $454.00 million the same period last year.

California Resources Q1 Adj. EPS $1.07 Beats $0.78 Estimate, Sales $912.00M Beat $861.21M Estimate

Denali Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DNLI#NASDAQ">DNLI</a>) reported quarterly losses of $(0.78) per share which missed the analyst consensus estimate of $(0.68) by 14.71 percent. This is a 14.71 percent decrease over losses of $(0.68) per share from the same period last year.

Earnings Misses

DNLI

Denali Therapeutics Q1 EPS $(0.78) Misses $(0.68) Estimate

W&amp;T Offshore (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WTI#NYSE">WTI</a>) reported quarterly losses of $(0.21) per share which missed the analyst consensus estimate of $(0.15) by 40 percent. This is a 320 percent decrease over losses of $(0.05) per share from the same period last year. The company reported quarterly sales of $129.87 million which beat the analyst consensus estimate of $123.91 million by 4.81 percent. This is a 7.76 percent decrease over sales of $140.79 million the same period last year.

W&T Offshore Q1 EPS $(0.21) Misses $(0.15) Estimate, Sales $129.87M Beat $123.91M Estimate

Qualys (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QLYS#NASDAQ">QLYS</a>) is looking for Q2 Adj EPS of $1.40-$1.50 vs $1.43 analyst estimate. sees sales of $159.700 million-$162.700 million vs $160.01 million analyst estimate.

QLYS

Qualys Sees Q2 Adj EPS $1.40-$1.50 vs $1.43 Est; Sees Sales $159.700M-$162.700M vs $160.01M Est

Unitil (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UTL#NYSE">UTL</a>) reported quarterly earnings of $1.69 per share which missed the analyst consensus estimate of $1.71 by 1.17 percent. This is unchanged from the same period last year. The company reported quarterly sales of $170.80 million which missed the analyst consensus estimate of $193.03 million by 11.52 percent. This is a 4.42 percent decrease over sales of $178.70 million the same period last year.

Unitil Q1 EPS $1.69 Misses $1.71 Estimate, Sales $170.80M Miss $193.03M Estimate

Lyra Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LYRA#NASDAQ">LYRA</a>) reported quarterly losses of $(0.13) per share which beat the analyst consensus estimate of $(0.15) by 13.33 percent. This is a 62.86 percent increase over losses of $(0.35) per share from the same period last year. The company reported quarterly sales of $183.00 thousand which missed the analyst consensus estimate of $240.00 thousand by 23.75 percent. This is a 65.60 percent decrease over sales of $532.00 thousand the same period last year.

LYRA

Lyra Therapeutics Q1 EPS $(0.13) Beats $(0.15) Estimate, Sales $183.00K Miss $240.00K Estimate

Aris Water Solutions (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ARIS#NYSE">ARIS</a>) reported quarterly earnings of $0.35 per share which beat the analyst consensus estimate of $0.29 by 20.69 percent. This is a 2.94 percent increase over earnings of $0.34 per share from the same period last year. The company reported quarterly sales of $120.49 million which beat the analyst consensus estimate of $112.46 million by 7.14 percent. This is a 16.52 percent increase over sales of $103.41 million the same period last year.

ARIS

Aris Water Solutions Q1 Adj. EPS $0.35 Beats $0.29 Estimate, Sales $120.49M Beat $112.46M Estimate

Agilon Health (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AGL#NYSE">AGL</a>) reported quarterly sales of $1.53 billion which beat the analyst consensus estimate of $1.50 billion by 1.92 percent. This is a 4.44 percent decrease over sales of $1.60 billion the same period last year.

Agilon Health Q1 Sales $1.53B Beat $1.50B Estimate

Stock Split

XChange TEC.INC Announces Plan To Implement ADS Ratio Change From 1 ADS Representing 120 Class A Shares To 1 ADS Representing 2,400 Class A Ordinary Shares

CRSP

CRISPR Therapeutics Q1 EPS $(1.58) Misses $(1.21) Estimate, Sales $865.00K

Upstart Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UPST#NASDAQ">UPST</a>) released its first-quarter results after Tuesday's closing bell. Here's a look at the key figures <a href="https://www.benzinga.com/pressreleases/25/05/b45235079/upstart-announces-results-for-first-quarter-2025">from the quarter.</a>
The Details: Upstart reported quarterly earnings of 30 cents per share, which beat the analyst consensus estimate of 17 cents. Quarterly revenue came in at $213.37 million, which beat the consensus estimate of $199.49 million and is up from revenue of $127.79 million from the same period last year.
Read Next:&nbsp; <a href="https://www.benzinga.com/news/legal/25/05/45226604/president-trump-wants-to-reopen-alcatraz-heres-what-it-would-take?utm_source=articleShare">President Trump Wants To Reopen Alcatraz: Here&#8217;s What It Would Take</a>
Upstart reported transaction volume of 240,706 loans originated, up 102% year-over-year, reflecting a 19.1% conversion rate. Total originations exceeded $2.1 billion, up 89% year-over-year.
&#8220;With an unparalleled pace of innovation, we continue to raise the bar in AI-enabled lending,&#8221; said Dave Girouard, CEO of Upstart. &#8220;In this foundational aspect of our economy, AI is clearly living up to its promise of delivering a radically better product for consumers.&#8221;
Outlook:&nbsp;For the second quarter of 2025, Upstart expects revenue of approximately $225 million and revenue from fees of approximately $210 million. For full-year 2025, Upstart now expects revenue of approximately $1.01 billion and revenue from fees of approximately $920 million. 
The company will host a conference call to discuss the results on Wednesday at 11:30 a.m. ET. 
UPST Price Action: According to data from <a href="https://pro.benzinga.com/?gspk=YWRhbWVja2VydDUzMzY&amp;gsxid=zBMR4PKmcgBw">Benzinga Pro</a>, Upstart stock was down 15.95% after-hours at $43.20 on Tuesday.  
Read Next:&nbsp;
<ul>
<li><a href="https://www.benzinga.com/analyst-ratings/analyst-color/25/05/45228179/upwork-delivers-solid-start-to-2025-analyst?utm_source=articleShare">Upwork Delivers &#8216;Solid Start To 2025&#8217;: Analyst&nbsp;</a></li>
</ul>
Photo: Shutterstock

Fintech news covering the emerging Financial Technology services sector

Fintech

After-Hours Center

Movers

UPST

Upstart Stock Drops After Q1 Results: Details

<a href="https://www.globenewswire.com/Tracker?data=ac8FbG8Cp_mK0uZG6iPrMAx5djulUrekP-fOeBOydXp4UMv9PxhXqPmsWO2ZH8F2wMHlBM9v9cZsy2a46haotw==">Cerence Inc.</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRNC#NASDAQ">CRNC</a>) ("Cerence AI"), a global leader pioneering conversational AI-powered user experiences, today announced the filing of a copyright infringement and breach of contract lawsuit against Microsoft and Nuance Communications in the United States District Court for the District of Delaware.
Cerence AI and its predecessors have an extensive history of industry-leading innovation and technological achievement. This has resulted in a strong intellectual property portfolio, which the company intends to protect through strategic, continued IP protection efforts. The lawsuit is specific to Cerence AI's text-to-speech technology, a foundational component of the company's product portfolio and its work with both automakers and transportation OEMs, as well as outside of automotive.
"At Cerence AI, we are deeply committed to having our intellectual property rights respected and enforced, especially as we continue to expand to new markets beyond automotive," said Jennifer Salinas, Chief Administrative Officer &amp; General Counsel, Cerence AI. "We believe in the strength of our intellectual property portfolio and plan to vigorously defend our intellectual property rights against infringers. This action against Microsoft and Nuance is necessary to protect our investments, as well as our deep history and culture of innovation."

Legal

CRNC

MSFT

Cerence AI Announces It Has Filed Copyright Infringement Suit Against Microsoft And Nuance

eXp World Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EXPI#NASDAQ">EXPI</a>) reported quarterly losses of $(0.07) per share which missed the analyst consensus estimate of $(0.01) by 600 percent. This is a 250 percent decrease over losses of $(0.02) per share from the same period last year. The company reported quarterly sales of $954.91 million which missed the analyst consensus estimate of $994.83 million by 4.01 percent. This is a 1.26 percent increase over sales of $943.05 million the same period last year.

EXPI

eXp World Holdings Q1 Adj. EPS $(0.07) Misses $(0.01) Estimate, Sales $954.91M Miss $994.83M Estimate

Electronic Arts (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EA#NASDAQ">EA</a>) is looking for Q1 GAAP EPS of $0.49-$0.66 vs $0.44 analyst estimate. sees sales of $1.550 billion-$1.650 billion vs $1.28 billion analyst estimate.

Electronic Arts Sees Q1 GAAP EPS $0.49-$0.66 vs $0.44 Est; Sees Sales $1.550B-$1.650B vs $1.28B Est

Electronic Arts (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EA#NASDAQ">EA</a>) is looking for Q1 Adj EPS of $(0.05)-$0.15 vs $0.52 analyst estimate. sees sales of $1.175 billion-$1.275 billion vs $1.28 billion analyst estimate.

Comments

Par Pacific Hldgs

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO